Latest filing published 02 Nov 2017 for ReShape Lifesciences Inc., €5,796.
Insider track record
Steven Ernest Johnson: trading record in brief
Steven Ernest Johnson discloses dealings in ReShape Lifesciences Inc. to SEC (Form 4). Over a trading history stretching from 30 April 2017 to 31 October 2017, the count stands at 2 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 2 November 2017 came the latest disclosure, a share grant for €5,796 in ReShape Lifesciences Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Steven Ernest Johnson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 942 shares@ US$7.1748.4% of flowCommon StockSEC:0001214659-17-006343:0
- 747 shares@ US$9.0351.6% of flowCommon StockSEC:0001214659-17-002939:0
2 of 2 declarations